Skip to main content

Table 1 Orally administered glucocorticoid (prednisone/prednisolone) dosing in the RITAZAREM trial

From: Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial

 

Induction schedule A

(1 mg/kg group)

Induction schedule B

(0.5 mg/kg group)

Week

<60 kg

≥60 kg

<60 kg

≥60 kg

0

50 mg/day

60 mg/day

25 mg/day

30 mg/day

2

35 mg/day

45 mg/day

20 mg/day

25 mg/day

4

25 mg/day

35 mg/day

17.5 mg/day

20 mg/day

6

20 mg/day

25 mg/day

15 mg/day

17.5 mg/day

8

15 mg/day

17.5 mg/day

12.5 mg/day

15 mg/day

10

12.5 mg/day

12.5 mg/day

12

10 mg/day

10 mg/day